Clinical Trial Update: Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature [Phase 4]

View source ↗

Summary

This completed Phase 4 trial investigates biochemical markers related to growth hormone response in children with idiopathic short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Idiopathic Short Stature | Phase 4 | Status: COMPLETED